The Radboudumc Board of Directors decided, after receiving advice from the UMC council, to change the Radboud Biobank business model. Departments are obliged to include biobank collections in the Radboud Biobank, based on (inter)national quality standards and Open Science, unless this is not possible for operational reasons which should be discussed with the Radboud Biobank team. In summary, departments pay for half of the biomaterial processing costs and for the storage of biomaterial. The Radboud Biobank makes use of the Radboudumc central freezer facility. Our storage rates are therefore based on the rates determined by the central freezer facility management. A graduated rate is used for issuance of samples and labor costs will be invoiced.
For new biobank collections the new business model has already been implemented. However, for existing biobank collections there is a transition phase of three years that will start on January 1, 2025. Researchers with existing biobank collections are requested to indicate if they should wish to terminate the processing and/or storage of biomaterial. Labor costs will be incurred for picking and destroying samples. Unless otherwise indicated, the Radboud Biobank will assume that researchers will proceed with existing collections under the new policy in 2025.
View an overview of the new rates here.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

One year since the new business model for the Radboud Biobank was implemented
3 March 2026The new business model was introduced last year, with departments paying half of the biomaterial processing costs, covering the storage costs, and applying a graduated rate for sample issuance.
go to page
Periodic invoicing biobank collections
3 March 2026Since 2025, the Radboud Biobank periodically charges all biobank collections for the processing and storage costs incurred.
go to page
The purpose of a central biobank facility such as the Radboud Biobank
3 March 2026As the central biobank facility of Radboudumc, the Radboud Biobank does more than simply store human biomaterials.
go to page
Radboud Biobank's 2025 annual report
3 March 2026The Radboud Biobank's 2025 annual report is now available on request.
go to page
Aevai Health developed a virtual assistant
3 March 2026Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.
go to page
Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials
21 October 2025Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.
go to page